"Deprescriptions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Directions written to discontinue use of PRESCRIPTION DRUGS in order to reduce unnecessary and/or excessive medications (see POLYPHARMACY), DRUG SIDE EFFECTS and ADVERSE DRUG REACTION.
| Descriptor ID |
D000069340
|
| MeSH Number(s) |
E02.319.698.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Deprescriptions".
Below are MeSH descriptors whose meaning is more specific than "Deprescriptions".
This graph shows the total number of publications written about "Deprescriptions" by people in this website by year, and whether "Deprescriptions" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 1 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 3 | 1 | 4 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Deprescriptions" by people in Profiles.
-
Deprescribing statins, considerations for informed decision making. J Am Geriatr Soc. 2023 08; 71(8):2685-2689.
-
Patient and Physician Perspectives of Deprescribing Potentially Inappropriate Medications in Older Adults with a History of Falls: a Qualitative Study. J Gen Intern Med. 2021 10; 36(10):3015-3022.
-
Short-Term Cessation of Dabigatran Causes a Paradoxical Prothrombotic State. Ann Neurol. 2021 03; 89(3):444-458.
-
Bridging Anticoagulation Therapy: A Teachable Moment. JAMA Intern Med. 2020 02 01; 180(2):311-312.
-
Clinical Characteristics and Adverse Impact of Hepatotoxicity due to Immune Checkpoint Inhibitors. Am J Gastroenterol. 2020 02; 115(2):251-261.
-
Physician practices for withdrawal of medications in inactive systemic juvenile arthritis, Childhood Arthritis and Rheumatology Research Alliance (CARRA) survey. Pediatr Rheumatol Online J. 2019 Jul 22; 17(1):48.
-
Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial). BMJ Open. 2019 07 09; 9(7):e028517.
-
Deprescribing in Older Adults With Cardiovascular Disease. J Am Coll Cardiol. 2019 05 28; 73(20):2584-2595.
-
The concomitant use of tyrosine kinase inhibitors and proton pump inhibitors: Prevalence, predictors, and impact on survival and discontinuation of therapy in older adults with cancer. Cancer. 2019 04 01; 125(7):1155-1162.
-
3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myasthenia. Muscle Nerve. 2018 04; 57(4):561-568.